Long-term immunosuppression after solitary islet transplantation is associated with preserved C-peptide secretion for more than a decade.


We report on two patients with type 1 diabetes (T1D) after solitary islet transplantation in 2001. They received steroid-sparing immunosuppression (daclizumab, sirolimus, and tacrolimus according to the Edmonton protocol). Both patients became insulin independent for 2 years: Patient A, a 42-year-old female with a 12-year history of T1D, received two islet… (More)
DOI: 10.1111/ajt.13383


4 Figures and Tables


Citations per Year

Citation Velocity: 6

Averaging 6 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.

Slides referencing similar topics